Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Mias Lymfterapi AB
AB
Active
Org 5590311055
Fjällstigen 8
Day spa, sauna and steam bath activities · NACE 9623
Est. 2015
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 82K
-20% vs 2023
EBITDA margin
-31.7%
-165% vs 2023
Equity ratio
95.0%
Financial strength
Net profit 2024
SEK -22K
-167% vs 2023
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
SEK 82K
-20%
EBITDA
SEK -26K
-165%
Net profit
SEK -22K
-167%
Total assets
SEK 240K
-13%
Equity
SEK 228K
-9%
Employees
1
—
Company information
Legal name
Mias Lymfterapi AB
Org number
5590311055
Legal form
Aktiebolag
NACE code
9623 · Day spa, sauna and steam bath activities
Founded
19 oktober 2015
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Kroppsvård, massage och därmed förenlig verksamhet.
Contact
Address
Fjällstigen 8
Email
miaslymfterapi@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Day spa, sauna and steam bath activities
Companies in Krokom
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
94
83
126
103
82
Staff expenses
—
—
—
—
—
EBITDA
29
17
50
40
−26
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
29
17
50
40
−26
Net financials
—
—
—
1
4
Profit before tax
29
18
50
41
−22
Tax
−6
−4
−10
−8
−0
Net profit
23
14
40
33
−22
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
189
197
248
277
240
Equity
164
178
217
251
228
Long-term debt
0
0
0
0
0
Short-term debt
25
19
31
27
12
Total debt
25
19
31
27
12
Financial ratios
5-year trend
EBITDA margin
-31.7%
This company
15.8%
Market median
-301% vs market
2020
2024
Equity ratio
95.0%
This company
38.2%
Market median
+149% vs market
2020
2024
Return on equity
-9.6%
This company
18.4%
Market median
-152% vs market
2020
2024
Net profit margin
-26.8%
This company
8.1%
Market median
-431% vs market
2020
2024
Asset turnover
0.34×
This company
1.12×
Market median
-70% vs market
2020
2024
Debt / equity
0.05×
This company
0.62×
Market median
+92% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
OR
Olov Roland Jonsson
Deputy Board Member
2022
BM
Britta Maria Nilsson
Board of Directors
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Mias Lymfterapi AB also hold positions in
0
other companies.
Person
Role here
Other companies
Olov Roland Jonsson
Deputy Board Member
0 companies
Britta Maria Nilsson
Board of Directors
0 companies